| 摘要 |
<p>The invention concerns an analysis method for diagnosing a prostate adenocarcinoma or a benign prostatic hypertrophy in a male patient, not involving prostate biopsy, using the combination of at least a tissue marker (PSA) and at least an inflammation marker (ACT) for the diagnosis. The invention also concerns a process using said method, an immunological test for implementing such a method and a diagnostic kit. The invention is applicable to the diagnosis of prostatic adenocarcinoma or benign prostatic hypertrophy.</p> |
